Uniunea Europeană - română - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil clorhidrat de - neoplasme colorectale - agenți antineoplazici - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Uniunea Europeană - română - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - neoplasme de stomac - agenți antineoplazici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Uniunea Europeană - română - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leucemie mieloidă - agenți antineoplazici - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

les laboratoires servier industrie - franta - combinatii (trifluridinum+tipiracilum) - compr. film. - 15 mg/6,14 mg - antimetaboliti analogi ai bazelor pirimidinice

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

les laboratoires servier industrie - franta - combinatii (trifluridinum+tipiracilum) - compr. film. - 20 mg/8,19 mg - antimetaboliti analogi ai bazelor pirimidinice

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

nordic pharma - olanda - combinatii (tegafur+gimeracil+oteracil) - caps. - 15mg/4,35mg/11,8mg - antimetaboliti analogi ai bazelor pirimidinice

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

nordic pharma - olanda - combinatii (tegafur+gimeracil+oteracil) - caps. - 20mg/5,8mg/15,8mg - antimetaboliti analogi ai bazelor pirimidinice